Transcriptional control of melanoma metastasis: The importance of the tumor microenvironment

被引:73
作者
Braeuer, Russell R. [1 ]
Zigler, Maya [1 ]
Villares, Gabriel J. [1 ]
Dobroff, Andrey S. [1 ]
Bar-Eli, Menashe [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Unit 173, Houston, TX 77030 USA
关键词
Melanoma; Metastasis; Transcription; Tumor microenvironment; PLATELET-ACTIVATING-FACTOR; CELL-ADHESION MOLECULES; GAP JUNCTIONAL COMMUNICATION; ELEMENT-BINDING PROTEIN; CUTANEOUS MALIGNANT-MELANOMA; ENDOTHELIAL GROWTH-FACTOR; SMALL INTERFERING RNA; HUMAN BREAST-CANCER; THROMBIN RECEPTOR; HUMAN MELANOCYTES;
D O I
10.1016/j.semcancer.2010.12.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The molecular changes associated with the transition of melanoma cells from radial growth phase (RGP) to vertical growth phase (VGP) and the metastatic phenotype are not very well defined. However, some of the genes involved in this process and their transcriptional regulation are beginning to be elucidated. For example, the switch from RGP to VGP and the metastatic phenotype is associated with loss of the AP-2 alpha transcription factor. AP-2 alpha regulates the expression of c-KIT, MMP-2, VEGF, and the adhesion molecule MCAM/MUC18. Recently, we reported that AP-2 alpha also regulates two G-protein coupled receptors (GPCRs) PAR-1 and PAFR. In turn, the thrombin receptor, PAR-1, regulates the expression of the gap junction protein Connexin-43 and the tumor suppressor gene Maspin. Activation of PAR-1 also leads to overexpression and secretion of proangiogenic factors such as IL-8, uPA, VEGF. PDGF, as well certain integrins. PAR-1 also cooperates with PAFR to regulate the expression of the MCAM/MUC18 via phosphorylation of CREB. The ligands for these GPCRs, thrombin and PAF, are secreted by stromal cells, emphasizing the importance of the tumor microenvironment in melanoma metastasis. The metastatic phenotype of melanoma is also associated with overexpression and function of CREB/ATF-1. Loss of AP-2 alpha and overexpression of CREB/ATF-1 results in the overexpression of MCAM/MUC18 which by itself contributes to melanoma metastasis by regulating the inhibitor of DNA binding-1 (Id-1). CREB/ATF-1 also regulates the angiogenic factor CYR-61. Our recent data indicate that CREB/ATF-1 regulates the expression of AP-2 alpha, thus, supporting the notion that CREB is an important "master switch" in melanoma progression. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:83 / 88
页数:6
相关论文
共 97 条
  • [91] Regulation of local and metastatic host-mediated anti-tumour mechanisms by L-selectin and intercellular adhesion molecule-1
    Yamada, M
    Yanaba, K
    Hasegawa, M
    Matsushita, Y
    Horikawa, M
    Komura, K
    Matsushita, T
    Kawasuji, A
    Fujita, T
    Takehara, K
    Steeber, DA
    Tedder, TF
    Sato, S
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2006, 143 (02) : 216 - 227
  • [92] CHARACTERIZATION OF THE PROMOTER REGION OF THE HUMAN C-KIT PROTOONCOGENE
    YAMAMOTO, K
    TOJO, A
    AOKI, N
    SHIBUYA, M
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 1993, 84 (11): : 1136 - 1144
  • [93] CHARACTERIZATION OF A HUMAN CDNA THAT ENCODES A FUNCTIONAL RECEPTOR FOR PLATELET-ACTIVATING-FACTOR
    YE, RD
    PROSSNITZ, ER
    ZOU, AH
    COCHRANE, CG
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 180 (01) : 105 - 111
  • [94] ZAKUT R, 1993, ONCOGENE, V8, P2221
  • [95] Connexin 43 expression promotes malignancy of HuH7 hepatocellular carcinoma cells via the inhibition of cell-cell communication
    Zhang, Dan
    Kaneda, Makoto
    Nakahama, Ken-ichi
    Arii, Shigeki
    Morita, Ikuo
    [J]. CANCER LETTERS, 2007, 252 (02) : 208 - 215
  • [96] A potent small molecule inhibits polyglutamine aggregation in Huntington's disease neurons and suppresses neurodegeneration in vivo
    Zhang, XQ
    Smith, DL
    Merlin, AB
    Engemann, S
    Russel, DE
    Roark, M
    Washington, SL
    Maxwell, MM
    Marsh, JL
    Thompson, LM
    Wanker, EE
    Young, AB
    Housman, DE
    Bates, GP
    Sherman, MY
    Kazantsev, AG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (03) : 892 - 897
  • [97] Zigler M, 2010, MINERVA MED, V101, P149